A Multi-Center Randomized Double-Blind Placebo-Controlled Trial of Xiongshao Capsule (芎芍胶囊) in Preventing Restenosis after Percutaneous Coronary Intervention: A Subgroup Analysis of Senile Patients

Qinghua Shang,Hao Xu,Xiao-yan Lu,Chuan Wen,Da-zhuo Shi,Ke-ji Chen

A Multi-Center Randomized Double-Blind Placebo-Controlled Trial of Xiongshao Capsule (芎芍胶囊) in Preventing Restenosis after Percutaneous Coronary Intervention: A Subgroup Analysis of Senile Patients

2011

Qinghua Shang
Hao Xu
Xiao-yan Lu
Chuan Wen
Da-zhuo Shi
Ke-ji Chen

Objective To evaluate the safety and efficacy of Xiongshao Capsule (芎芍胶囊, XS), consisting of Chuangxiongol and paeoniflorin, in preventing restenosis after percutaneous coronary intervention (PCI) in senile coronary heart disease (CHD) patients.

Keywords:

Percutaneous coronary intervention
Restenosis
Heart disease
Subgroup analysis
Medicine
Placebo-controlled study
Cardiology
Internal medicine
Angina
Clinical endpoint
Angioplasty
Myocardial infarction
Surgery
Conventional PCI

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations